Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The FDA says, The prescribing information for Wegovy contains a boxed warning to inform health care professionals and patients about the risk of thyroid C-cell tumors. As a result, the FDA warns that Wegovy not be used in patients with a personal or family history of medullary thyroid carcinoma or in patients with a rare condition called Multiple Endocrine Neoplasia syndrome type 2
10.1186/1471-2164-11-73 BMC Genomics 34 JiW.ZhuY.LiY.YangL.ZhaoX.CaiH.et al (2010)
These do not alter our adherence to journal policies on sharing data and materials
Li Y, Liu W, Li L, Hlscher C
US$ 24.93
US$ 21.97
US$ 25.67
US$ 28.97
US$ 20.62
